Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet. (Q45992748)
Jump to navigation
Jump to search
scientific article published on 19 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet. |
scientific article published on 19 May 2009 |
Statements
1 reference
Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet. (English)
1 reference
P Raskin
1 reference
A Lewin
1 reference
R Reinhardt
1 reference
W Lyness
1 reference
Repaglinide/Metformin Fixed-Dose Combination Study Group
1 reference
19 May 2009
1 reference
11
1 reference
9
1 reference
865-873
1 reference